Lumbar interbody fusion with neofuse    (DrugBank: -)

1 disease
告示番号疾患名(ページ内リンク)臨床試験数
70広範脊柱管狭窄症1

70. 広範脊柱管狭窄症 [臨床試験数:91,薬物数:195(DrugBank:54),標的遺伝子数:60,標的パスウェイ数:85
Searched query = "Spinal stenosis", "Extensive spinal canal stenosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 91 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00996073
(ClinicalTrials.gov)
September 20099/10/2009Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody FusionA Prospective, Multicenter, Randomized, Open-Label, Controlled Study Evaluating Safety and Preliminary Efficacy of NeoFuse When Combined With MasterGraft Matrix in Subjects Undergoing Lumbar Interbody Fusion With InstrumentationDegenerative Disc Disease;Degenerative Spondylolisthesis;Spinal StenosisBiological: Lumbar Interbody Fusion with Autograft;Biological: Lumbar Interbody Fusion with NeoFuseMesoblast, Ltd.NULLCompleted18 Years70 YearsAll24Phase 2United States